Characteristics and Treatment Patterns of Early Stage Melanoma: Results from a Multisite Chart Review - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Analysis of Early Stage Melanoma Management and Treatment Approaches: Findings from a Multicenter Chart Review

  • By

  • Collin M. Costello

  • Maria L. Wei

  • James Isaacs

  • Elizabeth M. Gaughan

  • Adina Greene

  • Alexandra So

  • Xiaochen Zhong

  • Jara Majuelos-Melguizo

  • Kavita Gandhi

  • Claudia Rey

  • Alicia Delibes

  • Rosemarie Barnett

  • Mizuho Fukunaga-Kalabis

  • Nawab Qizilbash

  • Irene M. Shui

  • Xiang-Lin Tan

  • September 19, 2026

Share

  • 1

    Early-stage cutaneous melanoma (IB–IIC) is primarily managed through surgery, often with sentinel lymph node biopsy, per NCCN guidelines.

  • 2

    As melanoma stage increases, systemic drug therapy and radiotherapy usage rise, with systemic therapy being predominant in second-line treatments.

  • 3

    Higher-stage melanoma is linked to receiving more treatment lines, indicating a need for novel therapies and optimized treatment sequencing.

  • 4

    The study aimed to characterize real-world treatment patterns for early-stage melanoma, highlighting gaps in current research and practice.

  • 5

    The investigation involved four US institutions and focused on patients aged ≥ 18 years with newly diagnosed stage IB–IIC melanoma.

Original Source(s)

Characteristics and Treatment Patterns of Early Stage Melanoma: Results from a Multisite Chart Review

  • by Collin M. Costello, Maria L. Wei, James Isaacs, Elizabeth M. Gaughan, Adina Greene, Alexandra So, Xiaochen Zhong, Jara Majuelos-Melguizo, Kavita Gandhi, Claudia Rey, Alicia Delibes, Rosemarie Barnett, Mizuho Fukunaga-Kalabis, Nawab Qizilbash, Irene M. Shui, Xiang-Lin Tan

  • September 19, 2026

Related Content

Clinician Counseling and Weight Loss Attempts Among Survivors of Obesity-Associated Cancers

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

The evolution of RTOG and NRG Oncology CNS tumors clinical trials